Fierce Health Payers January 6, 2022
The Biden administration wants Medicare Part D plans to apply any price concessions they get from drugmakers to the point-of-sale and require Medicare Advantage plans to be more transparent in how they spend money on supplemental benefits.
The Centers for Medicare and Medicaid Services released a proposed rule on late Thursday that outlined major regulatory changes for MA and Part D starting in 2023. The rule covers a swath of major areas that include new changes for dual-eligible special needs beneficiaries and updates to calculations of star ratings, which can affect quality bonuses delivered to plans.
“Today’s proposed actions follow our guiding principles by improving health equity and enhancing access to prescription medications,” said CMS Administrator Chiquita Brooks-LaSure in a...